Evidence map›Paper›PMID 24069412›Full record

ArticlePloS one2013

Solution-phase vs surface-phase aptamer-protein affinity from a label-free kinetic biosensor.

Camille Daniel, Yoann Roupioz, Didier Gasparutto, Thierry Livache, Arnaud Buhot

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. A smartphone aptasensor for fipronil detection in honey samples.Analytical and bioanalytical chemistry · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Sensing with Nanopores and Aptamers: A Way Forward.Sensors (Basel, Switzerland) · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Aptamer Microarrays-Current Status and Future Prospects.Microarrays (Basel, Switzerland) · 2015
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Camille DanielLaboratoire Structure et Propriétés d'Architectures Moléculaires, UMR 5819 CEA/CNRS/UJF, Institut Nanosciences et Cryogénie, Grenoble, France.
Yoann Roupioz
Didier Gasparutto
Thierry Livache
Arnaud Buhot
CEA Grenoble · FRCentre National de la Recherche Scientifique · FRStructure et Propriétés d'Architectures Moléculaires · FRUniversité Joseph Fourier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aptamers are selected DNA ligands that target biomolecules such as proteins. In recent years, they are showing an increasing interest as potential therapeutic agents or recognition elements in biosensor applications. In both cases, the need for characterizing the mating between the target and the aptamer either in solution or immobilized on a surface, is pressing. In this context, we have developed a kinetic biosensor made of micro-arrayed anti-thrombin aptamers to assess the kinetic parameters of this interaction. The binding of label-free thrombin on the biosensor was monitored in real-time by Surface Plasmon Resonance imaging. Remarkable performances were obtained for the quantification of thrombin without amplification (sub-nanomolar limit of detection and linear range of quantification to two orders of magnitude). The independent determinations of both the solution- and surface-phase affinities, respectively KD(Sol) and KD(Surf), revealed distinct values illustrating the importance of probes, targets or surface interactions in biosensors. Interestingly, KD(Surf) values depend on the aptamer grafting density and linearly extrapolate towards KD(Sol) for highly diluted probes. This suggests a lesser impact of the surface compared to the probe or target cooperativity interactions since the latter decrease with a reduced grafting density.

Indexed as

Biosensing TechniquesSurface Plasmon ResonanceAptamers, NucleotideHumansKineticsProtein BindingProteinsReproducibility of ResultsSolutionsThrombinAptamers, NucleotideProteinsSolutionsThrombinthrombin aptamer

Identifiers

PMID24069412
PMCPMC3775802
OpenAlexW1971741271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.